ANTIULCEROGENIC EFFECT OF CRYOPRESERVED PLACENTA EXTRACT AND THE EFFECT OF LOW TEMPERATURES ON THE DIGESTIVE TRACT INJURED BY DICLOFENAC SODIUM IN THE EXPERIMENT

  • Fedir. V. Hladkykh Institute for Problems of Cryobiology and Cryomedicine of the National Academy of Sciences of Ukraine, Kharkiv, Ukraine; State Organization «Grigoriev Institute for Medical Radiology and Oncology National Academy of Medical Sciences of Ukraine», Kharkiv, Ukraine https://orcid.org/0000-0001-7924-4048
  • Mykola O. Chyzh Institute for Problems of Cryobiology and Cryomedicine of the National Academy of Sciences of Ukraine, Kharkiv, Ukraine https://orcid.org/0000-0003-0085-296X
Keywords: cryopreserved placenta extract, nonsteroidal anti-inflammatory drugs, diclofenac sodium, NSAID gastropathy, NSAID enteropathy, antiulcer effect

Abstract

Introduction. Today, the ulcerogenic effect of nonsteroidal anti-inflammatory drugs is a key factor that significantly limits their clinical use and is a serious medical and social problem, as these drugs are among the most commonly used drugs – they are used annually by about 5­–7% of the world's population.

The aim is to characterize the antiulcerogenic effect of cryopreserved placenta extract and its application against the background of low temperatures in the model of diclofenac sodium-induced ulcerogenesis in rats according to macroscopic studies of the proximal and distal digestive tract.

Materials and methods of research. The study was performed on 42 male rats weighing 200–220 g. Acute diclofenac sodium-induced gastrointestinal damage was replicated by a single intragastric administration of diclofenac sodium to rats at a dose of 50 mg/kg. Euthanasia of animals was performed after 24 hours. The condition of the mucous membrane of the digestive tract was assessed on a scale and calculated integrated indicators – ulcer index and antiulcer activity. Cryocell-cryoextract of placenta was administered to rats intramuscularly at a dose of 0.16 ml/kg body weight. Cryoirrigation was performed once by local injection of liquid nitrogen vapor (temperature – 120˚C) for 10 s.

Results of the research. It was found that diclofenac sodium at a dose of 50 mg/kg led to erosive-ulcerative damage to the gastric mucosa in 100% of rats, and the ulcer index was 3.9. The most pronounced leveling of the ulcerogenic effect of diclofenac sodium was observed against the combined preventive use of placental cryoextract and low temperature effect – the ulcer index was 12.6 times lower than that of rats with diclofenac sodium-induced ulcerogenesis without correction. Macroscopic evaluation of the distal gastrointestinal tract showed that the introduction of diclofenac sodium led to a statistically significant (p < 0.05) lesion of the mucous membrane of the small and large intestine in 42.9% of rats.

Conclusions. According to the magnitude of antiulcer effect (%) in the model of diclofenac sodium-induced ulcerogenesis, the investigated prophylactic approaches for antiulcer activity have the following priority: action of low temperatures + cryoextract of placenta (96.7%) > cryoextract of placenta (92.1%) ~ esomeprazole (88.2%) > action of low temperatures (72.1%). No lesions of both the small and large intestine on the background of the introduction of placental cryoextract in the model of diclofenac sodium-associated ulcerogenesis were detected.

Author Biographies

Fedir. V. Hladkykh, Institute for Problems of Cryobiology and Cryomedicine of the National Academy of Sciences of Ukraine, Kharkiv, Ukraine; State Organization «Grigoriev Institute for Medical Radiology and Oncology National Academy of Medical Sciences of Ukraine», Kharkiv, Ukraine

аспірант відділу експериментальної кріомедицини, Інститут проблем кріобіології і кріомедицини Національної академії наук України, вул. Переяславська, буд. 23, м. Харків, 61016, Україна; молодший науковий співробітник групи променевої терапії Відділу радіології, Державна установа «Інститут медичної радіології та онкології імені С. П. Григор’єва Національної академії медичних наук України», вул. Пушкінська, буд. 82, м. Харків, 61024, Україна

тел.: +33 (099) 782-78-72,

e-mail: fedir.hladkykh@gmail.com,

ORCID: https://orcid.org/0000-0001-7924-40481,

Web of Science: M-5709-2017

Mykola O. Chyzh, Institute for Problems of Cryobiology and Cryomedicine of the National Academy of Sciences of Ukraine, Kharkiv, Ukraine

кандидат медичних наук, старший дослідник, в. о. завідувача відділом експериментальної кріомедицини, Інститут проблем кріобіології і кріомедицини Національної академії наук України, вул. Переяславська, буд. 23, м. Харків, 61016, Україна

тел.: +38 (066) 427-10-71,

e-mail: chizh.cryo@gmail.com,

ORCID: https://orcid.org/0000-0003-0085-296X

References

1. Czimmerman YS. Gastric or peptic ulcer: Non-steroidal anti-inflammatory drugs (NSAIDs): NSAID gastritis or NSAID gastropathy? Clinical pharmacologists and therapy. 2018;27(1):1–8.
2. Karateev AE, Nasonov EL, Yakhno NN, Ivashkin VT, Chichasova NV, Alekseeva LI, Karpov YuA, Evseev MA, Kukushkin ML, Danilov AB, Vorobyeva OV, Amelin AV, Novikova DS, Drapkina OM, Kopenkin SS, Abuzarova GR. Clinical guidelines «Rational use of nonsteroidal anti-inflammatory drugs (NSAIDs) in clinical practice». Modern Rheumatology Journal. 2015;9(1):4–23. DOI: https://doi.org/10.14412/1996-7012-2015-1-4-23
3. Amirdjanova VN, Karateev AЕ. New aspects of pain management in acute and chronic inflammatory syndromes. Modern Rheumatology Journal. 2021;15(1):73–78. DOI: https://doi.org/10.14412/1996-7012-2021-1-73-78
4. Maev IV, Andreev DN, Dicheva DT. Gastropathies induced by nonsteroidal anti-inflammatory drugs: pathogenetically determined approaches to prevention and therapy. Pharmacy. 2016;2:49–54.
5. Vyalov SS. Restoration of the mucous membrane of the gastrointestinal tract or reduction of gastric acidity? – лPriorities in treatment. Effective pharmacotherapy. 2016;1:1–9.
6. Lazebnik LB, Belova GV. Systemtizing classifi cation of multifocal lesions of the mucosa of the digestive tract by non-steroidal anti–infl amatory and antitrombotic drugs (“Moscow classifi cation”). Experimental and Clinical Gastroenterology. 2018;151(3):19–27.
7. Pellicano R. Gastrointestinal damage by non-steroidal anti-inflammatory drugs: updated clinical considerations. Minerva Gastroenterol Dietol. 2014;60(4):255–261.
8. Lim YJ, Lee JS, Ku YS, Hahm KB. Rescue strategies against non-steroidal anti-inflammatory drug-induced gastroduodenal damage. J. Gastroenterol. Hepatol. 2009;24:1169–78.
9. Hladkykh FV. Preventive and treatment strategies for pharmacocorrection of gastropathy induced by nonsteroidal anti-inflammatory drugs Reviews of clinical pharmacology and drug therapy. 2017;4:14–23. DOI: http://doi.org/10.17816/RCF15414-23
10. Hladkykh FV, Chyzh MO. Nonsteroidal anti-inflammatory drugs: a modern understanding of the mechanisms of damage to the digestive tract, the shortcomings of pathogenetic drugs and prospects for biological therapy of NSAID-induced esophagogastroenterocolonopathy. Gastroenterology. 2020;4:253–266. DOI: https://doi.org/10.22141/2308-2097.54.4.2020.216714
11. Gubskaya OYu, Kuzminets AA. NSAID enterotoxicity: focus on the problem. Modern Gastroenterology. 2018;5(103):50–59. DOI: http://doi.org/10.30978/MG-2018-5-50
12. Hladkykh FV, Chyzh MO. Modulation of meloxicam-induced changes in gastrointestinal and motor activity of the stomach by applying placenta cryoextract. Proceedings of the Shevchenko Scientific Society. Medical Sciences. 2021;64(1):84–94. DOI: https://doi.org/10.25040/ntsh2021.01.08
13. Hladkykh FV, Chyzh MO. The effect of cryoirrigation and cryopreserved placenta extract on the content of nitrogen monoxide in the gastric mucosa in rats with diclofenac sodium-induced gastropathy. The 58-th Annual Meeting of the Society for Cryobiology «CRYO 2021», 21–23 July, Chicago. 2021; Chicago. USA, 2021. p. 97–98.
14. Stefanov OV. Preclinical studies of drugs: guidelines. Kyiv: Avicenna; 2001. 527 p.
15. Stepanujk NG. Characteristics of the protective effect of quercetin and its water-soluble form of corvitin in a model of diclofenac-induced gastropathy. Georgian Med News. 2019; (296): 140–4.
16. Goltsev AN, ed. Placenta: cryopreservation, clinical use. Kharkiv; 2013. 268 p.
17. Pan SY, Chan MKS, Wong MBF, Klokol D, Chernykh V. Placental therapy: An insight to their biological and therapeutic properties. Journal of Medicine and Therapeutics. 2017;1(3):1–6. DOI: http://doi.org/10.15761/JMT.1000118
18. Rybolovlev YuR, Rybolovlev RS. Dosage of substances for mammals by constants of biological activity. Reports of the USSR Academy of Sciences. 1979;247(6):1513–6.
19. Wei Xie, Xielin Huang, Renpin Chen, Ruru Chen , Tang Li, Wei Wu, Zhiming Huang. Esomeprazole alleviates the damage to stress ulcer in rats through not only its antisecretory effect but its antioxidant effect by inactivating the p38 MAPK and NF-κB signaling pathways. Drug Design, Development and Therapy. 2019;22(13):2969–2984. DOI: http://doi.org/10.2147/DDDT.S193641
20. Hladkikh FV, Stepanuk NG, Vernygorodsky SV. Macro- and microscopic study of the effect of 2-phenyl-3-carbetoxy-4-dimethylaminomethyl-5-oxybenzofuran hydrochloride (vinborone) on gastrotoxicity ibuprofen in experimental rheumatoid arthritis in rats. Trajectory of Science: International Electronic Scientific Journal = Traektoriâ Nauki = Path of Science. 2017;10:7001–7018. DOI: http://dx.doi.org/10.22178/pos.27-8
21. Modlin IM, Hunt RH., Malfertheiner P, Moayyedi P, Quigley EM, Tytgat GN, Tack J, Heading RC, Holtman G, Moss SF. Diagnosis and management of non-erosive reflux disease – the Vevey NERD Consensus Group. Digestion. 2009;80 (2):74–88. DOI: https://doi.org/10.1159/000219365
22. Schneider NI, Plieschnegger W, Geppert M, Wigginghaus B, Hoess GM, Eherer A, Wolf EM, Rehak P, Vieth M, Langner C. Validation study of the Esohisto consensus guidelines for the recognition of microscopic esophagitis. Human pathology. 2014;45(5):994–1002. DOI: https://doi.org/10.1016/j.humpath.2013.12.013
Published
2021-09-29
How to Cite
Fedir. V. Hladkykh, & Mykola O. Chyzh. (2021). ANTIULCEROGENIC EFFECT OF CRYOPRESERVED PLACENTA EXTRACT AND THE EFFECT OF LOW TEMPERATURES ON THE DIGESTIVE TRACT INJURED BY DICLOFENAC SODIUM IN THE EXPERIMENT. Eastern Ukrainian Medical Journal, 9(3), 284-294. https://doi.org/10.21272/eumj.2021;9(3):284-294